We are live on ! Find out more
LPCN icon

Lipocine
LPCN

22 hedge funds and large institutions have $18.7M invested in Lipocine in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

29% more funds holding

Funds holding: 17 → 22 (+5)

21% less capital invested

Capital invested by funds: $23.7M → $18.7M (-$5.04M)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$941K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$165K
3
Millennium Management
Millennium Management
New York
+$119K
4
BFA
BlackRock Fund Advisors
California
+$76.5K
5
ARTA
A.R.T. Advisors
New York
+$67.5K

Top Sellers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
-$1.87M
2
GTC
Ghost Tree Capital
New York
-$561K
3
PCM
Prelude Capital Management
New York
-$421K
4
VKH
Virtu KCG Holdings
New York
-$162K
5
ISL
Ingalls & Snyder LLC
New York
-$20.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$6.34M – – –
VM
2
VHCP Management
New York
$3.52M – – –
BBA
3
Baker Bros. Advisors
New York
$2.63M – – –
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$2.1M – – –
RI
5
RTW Investments
New York
$1.1M +$1.04M +12,314 New
RA
6
Royce & Associates
New York
$996K +$941K +11,135 New
Millennium Management
7
Millennium Management
New York
$652K +$119K +1,406 +24%
Vanguard Group
8
Vanguard Group
Pennsylvania
$455K +$165K +1,954 +62%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$251K – – –
ISL
10
Ingalls & Snyder LLC
New York
$230K -$20.3K -240 -9%
Goldman Sachs
11
Goldman Sachs
New York
$119K -$19K -225 -14%
BFA
12
BlackRock Fund Advisors
California
$81K +$76.5K +906 New
ARTA
13
A.R.T. Advisors
New York
$71K +$67.5K +799 New
Morgan Stanley
14
Morgan Stanley
New York
$28K +$26.4K +312 +31,200%
Citigroup
15
Citigroup
New York
$26K +$24.8K +294 New
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$16K +$4.9K +58 +49%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$12K +$10.9K +129 New
BIM
18
BlackRock Investment Management
Delaware
$8K – – –
AIM
19
Advantage Investment Management
Iowa
$8K +$7.18K +85 New
Deutsche Bank
20
Deutsche Bank
Germany
$5K +$4.99K +59 New
UBS Group
21
UBS Group
Switzerland
$2K +$1.77K +21 New
JHIU
22
Janus Henderson Investors US
Colorado
– -$1.87M -18,024 Closed
GTC
23
Ghost Tree Capital
New York
– -$561K -5,398 Closed
PCM
24
Prelude Capital Management
New York
– -$421K -4,055 Closed
VKH
25
Virtu KCG Holdings
New York
– -$162K -1,581 Closed
1
2

LPCN Hedge Fund Activity: Q4 2014 in Review

22 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2014, worth a combined $18.7M — down 21% from $23.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LPCN positions and 4 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Royce & Associates, opening a new position worth an estimated $941K. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $1.87M sold.

  • 22 institutional investors held Lipocine (LPCN) as of Q4 2014, up from 17 in Q3 2014.
  • Funds reported $18.7M of Lipocine stock for Q4 2014, down 21% quarter-over-quarter.
  • 10 funds opened new Lipocine positions in Q4 2014 and 4 closed out, a net change of +6 holders.
  • The largest Lipocine buyer in Q4 2014 was Royce & Associates, an estimated $941K added.
  • The largest Lipocine seller in Q4 2014 was Janus Henderson Investors US, an estimated $1.87M sold.

Based on aggregated 13F filings for Q4 2014.